Lipid-mediated inflammation and degeneration of bioprosthetic heart valves

European Journal of Clinical Investigation

Volumn 39, Issue 6, 2009, Pages 471-480

  Shetty, R ^a   Pibarot, P ^a   Audet, A ^a   Janvier, R ^a   Dagenais, F ^a   Perron, J ^a   Couture, C ^a   Voisine, P ^a   Despres J P ^a   Mathieu, P ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Bioprostheses; Inflammation; Metalloproteinase; Oxidized LDL; Structural valve degeneration

Indexed keywords

CD36 ANTIGEN; CD68 ANTIGEN; GELATINASE B; GLYCOSAMINOGLYCAN; OXIDIZED LOW DENSITY LIPOPROTEIN;

AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEGENERATION; FEMALE; HEART VALVE PROSTHESIS; HUMAN; HUMAN TISSUE; INFLAMMATION; LIPID STORAGE; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION;

ADULT; AGED; AORTIC VALVE STENOSIS; BIOPROSTHESIS; CALCINOSIS; FEMALE; HEART VALVE PROSTHESIS; HUMANS; LIPOPROTEINS, LDL; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSTHESIS FAILURE; RISK FACTORS;

EID: 65549142731     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02132.x     Document Type: Article

References (36)

1. Ruel M, Kulik A, Rubens FD, Bedard P, Masters RG, Pipe AL et al. Late incidence and determinants of reoperation in patients with prosthetic heart valves. Eur J Cardiothorac Surg 2004 25 : 364 70. (Pubitemid 38340571)
2. Sacks MS, Schoen FJ. Collagen fiber disruption occurs independent of calcification in clinically explanted bioprosthetic heart valves. J Biomed Mater Res 2002 62 : 359 71. (Pubitemid 35332199)
3. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005 79 : 1072 80. (Pubitemid 40288798)
4. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006 26 : 1721 8. (Pubitemid 44305324)
5. Cote C, Pibarot P, Despres JP, Mohty D, Cartier A, Arsenault B et al. Association between circulating oxidized low-density lipoprotein and fibro-calcific remodeling of the aortic valve in aortic stenosis. Heart 2008 94 : 1175 80.
6. Ortlepp JR, Pillich M, Mevissen V, Krantz C, Kimmel M, Autschbach R et al. APOE alleles are not associated with calcific aortic stenosis. Heart 2006 92 : 1463 6. (Pubitemid 44578843)
7. Skowasch D, Schrempf S, Preusse CJ, Likungu JA, Welz A, Luderitz B et al. Tissue resident C reactive protein in degenerative aortic valves: correlation with serum C reactive protein concentrations and modification by statins. Heart 2006 92 : 495 8.
8. Charest A, Pepin A, Shetty R, Cote C, Voisine P, Dagenais F et al. Distribution of SPARC during neovascularisation of degenerative aortic stenosis. Heart 2006 92 : 1844 9.
9. Moura LM, Maganti K, Puthumana JJ, Rocha-Goncalves F, Rajamannan NM. New understanding about calcific aortic stenosis and opportunities for pharmacologic intervention. Curr Opin Cardiol 2007 22 : 572 7. (Pubitemid 47537942)
10. Farivar RS, Cohn LH. Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation. J Thorac Cardiovasc Surg 2003 126 : 969 75. (Pubitemid 37305677)
11. Nollert G, Miksch J, Kreuzer E, Reichart B. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg 2003 126 : 965 8. (Pubitemid 37305676)
12. Briand M, Pibarot P, Despres JP, Voisine P, Dumesnil JG, Dagenais F et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 2006 114 : I512 7. (Pubitemid 44297200)
13. Bottio T, Thiene G, Pettenazzo E, Ius P, Bortolotti U, Rizzoli G et al. Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants. J Thorac Cardiovasc Surg 2003 126 : 99 105. (Pubitemid 36909946)
14. Vyavahare N, Hirsch D, Lerner E, Baskin JZ, Schoen FJ, Bianco R et al. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms. Circulation 1997 95 : 479 88. (Pubitemid 27056217)
15. Chen W, Kim JD, Schoen FJ, Levy RJ. Effect of 2-amino oleic acid exposure conditions on the inhibition of calcification of glutaraldehyde cross-linked porcine aortic valves. J Biomed Mater Res 1994 28 : 1485 95. (Pubitemid 24374544)
16. Mohammadi S, Baillot R, Voisine P, Mathieu P, Dagenais F. Structural deterioration of the Freestyle aortic valve: mode of presentation and mechanisms. J Thorac Cardiovasc Surg 2006 132 : 401 6. (Pubitemid 44092866)
17. Chang MY, Potter-Perigo S, Tsoi C, Chait A, Wight TN. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem 2000 275 : 4766 73. (Pubitemid 30108866)
18. Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995 15 : 551 61.
19. Hakala JK, Oorni K, Pentikainen MO, Hurt-Camejo E, Kovanen PT. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans. Arterioscler Thromb Vasc Biol 2001 21 : 1053 8. (Pubitemid 34168668)
20. Paananen K, Kovanen PT. Proteolysis and fusion of low density lipoprotein particles independently strengthen their binding to exocytosed mast cell granules. J Biol Chem 1994 269 : 2023 31. (Pubitemid 24035409)
21. Guyton JR, Klemp KF, Mims MP. Altered ultrastructural morphology of self-aggregated low density lipoproteins: coalescence of lipid domains forming droplets and vesicles. J Lipid Res 1991 32 : 953 62.
22. Piha M, Lindstedt L, Kovanen PT. Fusion of proteolyzed low-density lipoprotein in the fluid phase: a novel mechanism generating atherogenic lipoprotein particles. Biochemistry 1995 34 : 10120 9.
23. Grabenwoger M, Grimm M, Eybl E, Kadletz M, Havel M, Kostler P et al. New aspects of the degeneration of bioprosthetic heart valves after long-term implantation. J Thorac Cardiovasc Surg 1992 104 : 14 21.
24. Greaves DR, Gordon S. Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res 2005 46 : 11 20.
25. Jones NL, Allen NS, Willingham MC, Lewis JC. Modified LDLs induce and bind to membrane ruffles on macrophages. Anat Rec 1999 255 : 44 56. (Pubitemid 29201066)
26. Vyavahare N, Ogle M, Schoen FJ, Zand R, Gloeckner DC, Sacks M et al. Mechanisms of bioprosthetic heart valve failure: fatigue causes collagen denaturation and glycosaminoglycan loss. J Biomed Mater Res 1999 46 : 44 50. (Pubitemid 29233179)
27. Ardans JA, Economou AP, Martinson JM Jr., Zhou M, Wahl LM. Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes. J Leukoc Biol 2002 71 : 1012 8.
28. Tayebjee MH, Lip GY, Macfadyen RJ. Matrix metalloproteinases in coronary artery disease: clinical and therapeutic implications and pathological significance. Curr Med Chem 2005 12 : 917 25. (Pubitemid 40443847)
29. Mohty D, Pibarot P, Despres JP, Cote C, Arsenault B, Cartier A et al. Association between plasma LDL particle size, valvular accumulation of oxidized LDL, and inflammation in patients with aortic stenosis. Arterioscler Thromb Vasc Biol 2008 28 : 187 93.
30. Manji RA, Zhu LF, Nijjar NK, Rayner DC, Korbutt GS, Churchill TA et al. Glutaraldehyde-fixed bioprosthetic heart valve conduits calcify and fail from xenograft rejection. Circulation 2006 114 : 318 27. (Pubitemid 44297098)
31. Antonini-Canterin F, Zuppiroli A, Popescu BA, Granata G, Cervesato E, Piazza R et al. Effect of statins on the progression of bioprosthetic aortic valve degeneration. Am J Cardiol 2003 92 : 1479 82. (Pubitemid 37532579)
32. Moura LM, Ramos SF, Zamorano JL, Barros IM, Azevedo LF, Rocha-Goncalves F et al. Rosuvastatin affecting aortic valve endothelium to slow the progression of aortic stenosis. J Am Coll Cardiol 2007 49 : 554 61. (Pubitemid 46177435)
33. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB et al. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005 352 : 2389 97. (Pubitemid 40958435)
34. Mathieu P, Pibarot P, Despres JP. Metabolic syndrome: the danger signal in atherosclerosis. Vasc Health Risk Manag 2006 2 : 285 302. (Pubitemid 44275464)
35. Reiss AB, Vagell ME. PPARgamma activity in the vessel wall: anti-atherogenic properties. Curr Med Chem 2006 13 : 3227 38. (Pubitemid 44680866)
36. Skowasch D, Steinmetz M, Nickenig G, Bauriedel G. Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology. Expert Rev Med Devices 2006 3 : 453 62. (Pubitemid 44144980)